Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Chung

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Cancer|October 13, 2011
The clinical and functional outcome for patients with radiation-induced soft tissue sarcomaSoha Riad, David Biau, Ginger E Holt, et al.
Nature Communications|November 15, 2022
Releasing chemical energy in spatiallyprogrammed ferroelectricsYong Hu, Jennifer L Gottfried, Rose Pesce-Rodriguez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillanceChristian Kollmannsberger, Torgrim Tandstad, Philippe L Bedard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2025
The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trialKara M Ruicci, Aisling Barry, Xiang Y Ye, et al.
BMJ Open|April 25, 2020
[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trialRachel M Glicksman, Ur Metser, John Valliant, et al.
Journal of Surgical Oncology|February 9, 2019
Low dose radiotherapy is associated with local complications but not disease control in sacral chordomaMatthew T Houdek, Peter S Rose, Mario Hevesi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2022
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate CancerRachel M Glicksman, Matthew Ramotar, Ur Metser, et al.
Cancer|January 3, 2019
Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working GroupRick L M Haas, Sylvie Bonvalot, Rosalba Miceli, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2019
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcomaMarilyn Heng, Abha Gupta, Peter W Chung, et al.
Cancer|May 10, 2022
Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the EORTC 62092-22092 STRASS trialRick Haas, Jean-Jacques Stelmes, Facundo Zaffaroni, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cancer|October 13, 2011
The clinical and functional outcome for patients with radiation-induced soft tissue sarcomaSoha Riad, David Biau, Ginger E Holt, et al.
Nature Communications|November 15, 2022
Releasing chemical energy in spatiallyprogrammed ferroelectricsYong Hu, Jennifer L Gottfried, Rose Pesce-Rodriguez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillanceChristian Kollmannsberger, Torgrim Tandstad, Philippe L Bedard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2025
The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trialKara M Ruicci, Aisling Barry, Xiang Y Ye, et al.
BMJ Open|April 25, 2020
[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trialRachel M Glicksman, Ur Metser, John Valliant, et al.
Journal of Surgical Oncology|February 9, 2019
Low dose radiotherapy is associated with local complications but not disease control in sacral chordomaMatthew T Houdek, Peter S Rose, Mario Hevesi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2022
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate CancerRachel M Glicksman, Matthew Ramotar, Ur Metser, et al.
Cancer|January 3, 2019
Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working GroupRick L M Haas, Sylvie Bonvalot, Rosalba Miceli, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2019
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcomaMarilyn Heng, Abha Gupta, Peter W Chung, et al.
Cancer|May 10, 2022
Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the EORTC 62092-22092 STRASS trialRick Haas, Jean-Jacques Stelmes, Facundo Zaffaroni, et al.
Pageof 5